Literature DB >> 12498903

Interactions of the narcotic l-alpha-acetylmethadol with human cardiac K+ channels.

Jiesheng Kang1, Xiao Liang Chen, Hongge Wang, David Rampe.   

Abstract

l-alpha-acetylmethadol is a long-acting narcotic analgesic that is used in the treatment of opiate addiction. However, the drug has been associated with cases of QT interval prolongation and ventricular arrhythmia. To understand the mechanism underlying these clinical findings, we examined the effects of l-alpha-acetylmethadol on the cloned human cardiac K(+) channels HERG (human ether-a-go-go-related gene), KvLQT1/minK and Kv4.3. Using patch clamp electrophysiology, we found that l-alpha-acetylmethadol inhibited HERG channel currents in a voltage-dependent manner displaying an IC(50) value of 3 microM. The major active metabolite of l-alpha-acetylmethadol, noracetylmethadol, inhibited HERG with an estimated IC(50) values of 12 microM. l-alpha-acetylmethadol had little or no effect on Kv4.3 or KvLQT1/minK K(+) channel currents at concentration up to 10 microM. We conclude that the proarrhythmic effects of l-alpha-acetylmethadol are due to specific blockade of the HERG cardiac K(+) channel and that its active metabolite noracetylmethadol may provide a safer alternative in the treatment of opiate addiction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12498903     DOI: 10.1016/s0014-2999(02)02700-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Syncope of a drug addict - a special case.

Authors:  Bidisha Chatterjee; Ulrich Bürgi
Journal:  Clin Res Cardiol       Date:  2006-08-01       Impact factor: 5.460

2.  Blood-brain equilibration kinetics of levo-alpha-acetyl-methadol using a chronically instrumented sheep preparation.

Authors:  David J R Foster; Mette L Jensen; Richard N Upton; Andrew A Somogyi; Cliff Grant; Allison Martinez
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 3.  Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.

Authors:  Chloe J Jordan; Jianjing Cao; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-04-19       Impact factor: 5.250

4.  Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.

Authors:  W Victor R Vieweg; Mehrul Hasnain; Robert H Howland; Thomas Clausen; Jayanthi N Koneru; Christopher Kogut; Ericka L Breden Crouse; Jules C Hancox; Antony Fernandez; Ananda K Pandurangi
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

5.  A community-based evaluation of sudden death associated with therapeutic levels of methadone.

Authors:  Sumeet S Chugh; Carmen Socoteanu; Kyndaron Reinier; Justin Waltz; Jonathan Jui; Karen Gunson
Journal:  Am J Med       Date:  2008-01       Impact factor: 4.965

6.  Inhibition of HERG potassium channels by celecoxib and its mechanism.

Authors:  Roman V Frolov; Irina I Ignatova; Satpal Singh
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

7.  Genome-wide association study of stimulant dependence.

Authors:  Jiayi Cox; Richard Sherva; Leah Wetherill; Tatiana Foroud; Howard J Edenberg; Henry R Kranzler; Joel Gelernter; Lindsay A Farrer
Journal:  Transl Psychiatry       Date:  2021-06-29       Impact factor: 6.222

Review 8.  The Impact of Opioids on Cardiac Electrophysiology.

Authors:  Erich F Wedam; Mark C Haigney
Journal:  Curr Cardiol Rev       Date:  2016
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.